2020
DOI: 10.1016/j.ijpharm.2020.119347
|View full text |Cite
|
Sign up to set email alerts
|

Nanoparticle albumin-bound mTHPC for photodynamic therapy: Preparation and comprehensive characterization of a promising drug delivery system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 28 publications
0
12
0
Order By: Relevance
“…The formation of nanoparticle pockets enhanced the encapsulation property of the system. Stein et al [ 102 ] studied the preparation of stable mTHPC-albumin nanoparticles using nanoparticle albumin-bound (nab)-technology to develop a system for drugs that are not very water-soluble. In this study, the advantages of nanotechnology and albumin with the ability of high tumor enrichment and the selective light initiation of the photosensitizer Temoporfin (mTHPC) were associated with a new delivery system for reliable tumor treatment.…”
Section: Albumin-based Nanoparticlesmentioning
confidence: 99%
“…The formation of nanoparticle pockets enhanced the encapsulation property of the system. Stein et al [ 102 ] studied the preparation of stable mTHPC-albumin nanoparticles using nanoparticle albumin-bound (nab)-technology to develop a system for drugs that are not very water-soluble. In this study, the advantages of nanotechnology and albumin with the ability of high tumor enrichment and the selective light initiation of the photosensitizer Temoporfin (mTHPC) were associated with a new delivery system for reliable tumor treatment.…”
Section: Albumin-based Nanoparticlesmentioning
confidence: 99%
“…Specifically, Temoporfin (mTHPC), a photosensitizer, was incorporated into the Nab system to mitigate prolonged infusion rates and adverse side effects with the commercially available Foscan, which is formulated with ethanol and propylene glycol. [ 66 ]…”
Section: Nanoparticle Albumin Bound Technologymentioning
confidence: 99%
“…Specifically, Temoporfin (mTHPC), a photosensitizer, was incorporated into the Nab system to mitigate prolonged infusion rates and adverse side effects with the commercially available Foscan, which is formulated with ethanol and propylene glycol. [66] In summary, Nab technology is a fabrication method of albumin nanoparticles encapsulating hydrophobic drugs through a combination of high shear, cavitation, and pressure. Nab technology is the first commercialized nanomedicine (Abraxane) after FDA approvement in 2005.…”
Section: Water Miscible Organic Solventmentioning
confidence: 99%
“…Stein et al formulated mTHPC-albumin nanoparticles using nab-technology [169]. Nanoparticles showed colloidal stability over a wide range of pH and in physiological NaCl with different concentrations.…”
Section: Encapsulation Of Biologicsmentioning
confidence: 99%